Introduction to Systematic Reviews & Meta-Analysis
-
Conferences
-
Upcoming Conferences
- ISPOR 2019
- ISPOR Latin America Summit 2019
- ISPOR Latin America 2019
- ISPOR Europe 2019
-
ISPOR Summit 2019
- Past Conferences
- Register
- Submit Abstract
- Exhibits & Sponsorships
- Awards & Grants
-
Upcoming Conferences
-
Education & Training
- In-Person Training
-
Virtual Training
-
Distance Learning
- Introduction to Outcomes Research
- Introduction to Systematic Reviews & Meta-Analysis
- Systematic Review & Meta-Analysis: Applications
- Introduction to Pharmacoeconomics
- Cost-of-Illness/Cost-Estimation (COI/CE)
- Cost-Minimization/Cost-Consequence (CMA/CCA)
- Cost-Effectiveness Analysis (CEA) and Cost-Utility Analysis (CUA)
- Modeling Health Care Costs – Part I: Characteristics of Health Care Costs
- Modeling Health Care Costs – Part II: Methods and Guidelines for Estimating Health Care Costs
- Modeling Health Care Costs – Part III: Estimation from Censored Data
- Introduction to Budget Impact Analysis (BIA) - Part I
- Introduction to Budget Impact Analysis (BIA) - Part II
- Markov Model Toolkit: Concepts, Assumptions and Examples
- An Introduction to Choice-Based Conjoint Analysis (Discrete Choice Experiments)
- Health-Related Quality of Life (HRQOL) – Basics
- Patient Reported Outcomes: Analysis and Interpretation
- Patient Reported Outcomes: Instrument Development
- Item Response Theory: A Conceptual Introduction
- Preparing for Multinational Clinical Trials: Translation and Cultural Adaptations of PRO Measures
- Evidence Generation for Patient Reported Outcome (PRO) Label Claims (FDA Requirements)
- Intermediate Retrospective Observational Study - Propensity Scoring Methods
- Use of Public Survey Data in Health Outcomes Research
-
Webinars
- Using RWE to Improve Healthcare Decision-making in Asia Pacific
- Top 10 HEOR Trends of 2019
- The Use of MCDA for HTA Agencies
- MCDA - How to Guide of Different Methods for Assessment of Rare Disease HT
- Virtualizing Long-Term Follow-Up Studies for Gene Therapy Products
- Is the FDA's New Guidance a Watershed Moment for Real-world Evidence?
-
Distance Learning
-
Calendar
Faculty
Course Description
Systematic Review, also known as a structured literature review, summarizes a topic in a fashion using preset criteria and a protocol. On the other hand meta-analysis is both a systematic literature review and a quantitative synthesis of finding across multiple studies.
This module will delve into the environmental context in which evidence-based medicine (EBM) has arisen, and how the development of systematic review methodology has become the chief tool of EBM. Students will be shown how to step-by-step perform a systematic review, and in so doing, they will learn how to evaluate systematic reviews that have already been conducted by others. Additionally, two major groups within systematic review will reviewed. These major groups are the “producers” and the “consumers” of systematic reviews. The way in which various stakeholders are currently using systematic reviews for decision-making and how they should be using them now and in the future will also be discussed.
Learning Objectives
By the end of the Introduction to Systematic Reviews & Meta-Analysis module, you will be able to:
- Understand how to perform and how to critically appraise systematic reviews and meta-analyses of drug trials.
- Appreciate the pros and cons of using systematic reviews to inform healthcare policy and practice decisions re: the efficacy, effectiveness, and safety of drugs.
- Learn how systematic reviews/meta-analyses are and will be used for drug development and commercialization activities by industry.